Kaiser Permanente Hawaii — Honolulu, Hawaii

Kaiser Permanente Hawaii is a clinical research site located in Honolulu, Hawaii, United States 96819.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Kaiser Permanente Hawaii has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: NSCLC, HER2-positive Breast Cancer, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive.

Sponsors: Eikon Therapeutics, Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Hawaii?

Kaiser Permanente Hawaii has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Hawaii conducted?

Kaiser Permanente Hawaii has 12 clinical trials on record, with 3 currently active. Their work covers NSCLC, HER2-positive Breast Cancer, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive.

Is Kaiser Permanente Hawaii accredited by Crixeo Clinical Trials?

Kaiser Permanente Hawaii has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Hawaii?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.